Full text is available at the source.
JAMA surgery···
Roux-en-Y Gastric Bypass and Changes in Health Care Use and Costs After Surgery in Canada
Updated
Abstract
Mean total health care expenditures per patient in the Roux-en-Y gastric bypass (RYGB) group increased by CAD $14,795 over 5 years post-procedure.
- Total health care expenditures for the RYGB group rose from CAD $15,594 before surgery to CAD $30,389 after surgery.
- In contrast, expenditures for the control group increased from CAD $16,109 to CAD $20,073 over the same period.
- The overall difference-in-differences estimate indicates a net cost of RYGB of CAD $10,831 over 5 years.
- Increased hospitalizations shortly after RYGB contributed significantly to the higher costs.
- Expenditures stabilized in the third year post-surgery, with no statistically significant differences noted in years 4 and 5.
Simplified
IMPORTANCE: Results of previous studies are mixed regarding the economic implications of a Roux-en-Y gastric bypass (RYGB).
OBJECTIVE: To assess the 5-year incremental health care use and expenditures after RYGB.
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study conducted in Ontario, Canada, used a difference-in-differences approach to compare health care use and expenditures between patients who underwent a publicly funded RYGB from March 1, 2010, to March 31, 2013, and propensity score-matched control individuals who did not undergo a surgical bariatric procedure. The study period allowed for a minimum 60 months of follow-up because, at that time, the most recent date for which administrative data on health care and expenditures were available was March 31, 2018. Data sources included the Ontario Bariatric Registry linked to several Ontario health administrative databases and the Electronic Medical Record Administrative Data Linked Database. Health care use and expenditures data for 5 years before and 5 years after the index date (procedure date for RYGB group; random date for controls) were analyzed. Data analyses were performed March 12, 2019, to March 10, 2020.
INTERVENTION: RYGB procedure.
MAIN OUTCOMES AND MEASURES: The primary outcome was total health care expenditures.
RESULTS: The final propensity score-matched cohorts comprised 1587 individuals in the RYGB group (mean [SD] age, 47 [10.2] years) and 1587 controls (mean [SD] age, 47 [12.2] years); each group had 1228 women (77.4%) and a mean body mass index (calculated as weight in kilograms divided by height in meters squared) of 46. Mean total health care expenditures (2017 Canadian dollars) per patient in the RYGB group increased from CAD $15 594 (95% CI, CAD $14 743 to CAD $16 614) (US $12 008 [95% CI, US $11 353 to US $12 794]) in the 5 years before the procedure to CAD $30 389 (95% CI, CAD $28 789 to CAD $32 232) (US $23 401 [95% CI, US $22 169 to US $24 821]) over the 5 years after the procedure, a difference of CAD $14 795 (95% CI, CAD $13 172 to CAD $16 480) (US $11 393 [95% CI, US $10 143 to US $12 691]). For the control group, mean total health care expenditures per individual increased from CAD $16 109 (95% CI, CAD $14 727 to CAD $17 591) (US $12 405 [95% CI, US $11 341 to US $13 546]) 5 years before the index date to CAD $20 073 (95% CI, CAD $18 147 to CAD $22 169) (US $15 457 [95% CI, US $13 974 to US $17 071]) 5 years after the date, a difference of CAD $3964 (95% CI, CAD $2250 to CAD $5875) (US $3053 [95% CI, US $1733 to US $4524]). Overall, the difference-in-differences estimate of the net cost of RYGB was CAD $10 831 (95% CI, CAD $8252 to CAD $13 283) (US $8341 [95% CI, $6355 to $10 229]) over the 5-year period. This amount excluded the mean (SD) cost associated with the index date: CAD $6501 (CAD $1087) (US $5006 [US $837]) for the RYGB cohort and CAD $9 (CAD $72) (US $7 [US $55]) for the controls. The cost differential was primarily associated with increased hospitalizations in the first months immediately after RYGB. Expenditures leveled off in year 3 after the index date; differences in total expenditures between the RYGB and control cohorts were not statistically significantly different in years 4 and 5.
CONCLUSIONS AND RELEVANCE: Health care expenditures in the 3 years after publicly funded RYGB were higher in patients who underwent the procedure than in control individuals, but the costs were similar thereafter. This finding suggests the need to decrease hospital and emergency department readmissions after surgical bariatric procedures because such use is associated with increased spending.
Related papers
Sep '21
Four-Year Health Care Costs After Two Types of Weight-Loss Surgery: Gastric Bypass vs Sleeve Gastrectomy
top 2% journal
cited by 7 papers
comparative study
Jun '15
Medical Costs and Use After Two Types of Weight-Loss Surgery: Adjustable Gastric Banding vs. Gastric Bypass
top 2% journal
cited by 12 papers
comparative study
May '22
Health Care Costs and Use After Gastric Bypass Compared to Sleeve Gastrectomy
top 2% journal
cited by 7 papers
research support, n.i.h., extramural
Jul '19
Hospital use in the 4 years after sleeve gastrectomy versus Roux-en-Y gastric bypass surgery
top 20% journal
cited by 3 papers
multicenter study
Feb '22
Cost-effectiveness of Medicine, Sleeve Gastrectomy, and Gastric Bypass for Severe Obesity with Type 2 Diabetes
top 2% journal
cited by 50 papers
research support, n.i.h., extramural
Dec '22
Link Between Weight-Loss Surgery, Hospital Visits for Alcohol Problems, and Overall Death Rates in Veterans
top 2% journal
cited by 36 papers
research support, non-u.s. gov't
Dec '19
Risk of Surgery and Other Treatments Within 4 Years After Two Types of Weight-Loss Surgery in US Insured Patients
top 2% journal
cited by 38 papers
observational study
May '19
Fracture risk after two types of weight-loss surgery in Medicare patients: gastric bypass versus adjustable band
top 2% journal
cited by 45 papers
multicenter study